Keyword Analysis & Research: biogen
Keyword Research: People who searched biogen also searched
Search Results related to biogen on Search Engine
-
Home | Biogen
https://www.biogen.com/
WEBBiogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through …
DA: 61 PA: 8 MOZ Rank: 13
-
Biogen Inc. (BIIB) Stock Price, News, Quote & History - Yahoo Finance
https://finance.yahoo.com/quote/BIIB/
WEB39.60. -0.88%. Find the latest Biogen Inc. (BIIB) stock quote, history, news and other vital information to help you with your stock trading and investing.
DA: 67 PA: 47 MOZ Rank: 24
-
Company | Biogen
https://www.biogen.com/company.html
WEBBiogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through …
DA: 62 PA: 33 MOZ Rank: 75
-
Biogen - Wikipedia
https://en.wikipedia.org/wiki/Biogen
WEBBiogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. Biogen operates in Argentina, Brazil, Canada, China, France, Germany, Hungary, India, Italy, Japan ...
DA: 21 PA: 98 MOZ Rank: 40
-
Pipeline | Biogen
https://www.biogen.com/science-and-innovation/pipeline.html
WEBBreaking New Ground With Science. With a strong focus on difficult-to-treat diseases, our pipeline is focused on research in therapeutic areas where we believe we have the best opportunity to deliver transformational medicines to patients and protect public health.
DA: 24 PA: 38 MOZ Rank: 83
-
New Alzheimer’s drug Leqembi is granted full FDA approval - NBC News
https://www.nbcnews.com/health/health-news/leqembi-alzheimers-drug-fda-approval-eisai-biogen-rcna92377
WEBJul 6, 2023 · Leqembi, from Japanese drugmaker Eisai and U.S.-based drugmaker Biogen, targets a type of protein in the brain called beta-amyloid, long thought by scientists to be one of the underlying causes of ...
DA: 46 PA: 46 MOZ Rank: 38
-
Biogen’s Alzheimer’s drug approved by FDA, first new therapy in …
https://www.cnbc.com/2021/06/07/fda-approves-biogens-alzheimers-drug-the-first-new-therapy-for-the-disease-in-nearly-two-decades.html
WEBJun 7, 2021 · The Food and Drug Administration on Monday approved Biogen ’s Alzheimer’s disease drug aducanumab, making it the first medication cleared by U.S. regulators to slow cognitive decline in people ...
DA: 88 PA: 74 MOZ Rank: 18
-
Biogen | Investor Relations
https://investors.biogen.com/
WEBMar 12, 2024 · Founded in 1978, Biogen is a leading global biotechnology company that has pioneered multiple breakthrough innovations including a broad portfolio of medicines to treat multiple sclerosis, the first approved treatment for spinal muscular atrophy, and two co-developed treatments to address a defining pathology of Alzheimer’s disease, the first ...
DA: 12 PA: 36 MOZ Rank: 98
-
FDA Grants Accelerated Approval for QALSODY™ (tofersen) for ... - Biogen
https://investors.biogen.com/news-releases/news-release-details/fda-grants-accelerated-approval-qalsodytm-tofersen-sod1-als
WEBCAMBRIDGE, Mass., April 25, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced today that the U.S. Food and Drug Administration (FDA) has approved QALSODY™ (tofersen) 100 mg/15mL injection for the treatment of amyotrophic lateral sclerosis (ALS) in adults who have a mutation in the superoxide dismutase 1 ( SOD1) gene.
DA: 46 PA: 34 MOZ Rank: 50
-
FDA approves Alzheimer's drug from Biogen, against experts' …
https://www.nbcnews.com/health/aging/fda-approves-controversial-alzheimer-s-drug-biogen-n1269645
WEBJun 7, 2021 · The FDA has approved a new drug for Alzheimer's, from drugmaker Biogen. The drug is not without controversy. Many independent experts have questioned whether it works.
DA: 5 PA: 24 MOZ Rank: 31
